ACRS

Aclaris Therapeutics, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1557746Held by 5 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

5 managers · Q2 2026 13F

13F bookWeight

Vivo Capital

Vivo CapitalPosition history →

3.2%

+0.4%

$35.4M

$1.10B13F book · 2026-06-30

RA Capital Management

RA Capital ManagementPosition history →

0.58%

+87.0%

$67.3M

$11.51B13F book · 2026-06-30

OrbiMed Advisors

OrbiMed AdvisorsPosition history →

0.04%

NEW

$2.2M

$5.25B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.03%

+5.2%

$21.5M

$71.32B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

<0.01%

+44.4%

$0.7M

$21.33B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.